European Neuropsychopharmacology

Introduction: the implications for public health of controls on the benzodiazepines
pp. 391-392(2)
Author: Costa e Silva J.A.

Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997
pp. 393-398(6)
Authors: Uhlenhuth E.H.; Balter M.B.; Ban T.A.; Yang K.

Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
pp. 399-405(7)
Author: Lader M.H.

The use of benzodiazepines in anxiety and other disorders
pp. 407-412(6)
Authors: Argyropoulos S.V.; Nutt D.J.

The use and development of anxiolytics in Japan
pp. 413-419(7)
Author: Yamawaki S.